Pillar Pacific Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Pillar Pacific Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-990	Closed	-$138K	–	324
2020 Q4	$138K	Hold	990	–	–	0.01%	309
2020 Q3	$150K	Hold	990	–	–	0.01%	293
2020 Q2	$174K	Hold	990	–	–	0.02%	282
2020 Q1	$141K	Buy	+990	New	+$131K	0.02%	260
2015 Q4	–	Sell	-43	Closed	-$48K	–	297
2015 Q3	$48K	Hold	43	–	–	0.01%	288
2015 Q2	$44K	Hold	43	–	–	0.01%	288
2015 Q1	$44K	Sell	43 -2	-4%	-$6.6K	0.01%	288
2014 Q4	$148K	Sell	45 -1	-2%	-$3.07K	0.03%	278
2014 Q3	$133K	Hold	46	–	–	0.02%	294
2014 Q2	$175K	Hold	46	–	–	0.03%	288
2014 Q1	$250K	Buy	46 +1	+2%	+$5.27K	0.05%	243
2013 Q4	$140K	Buy	+45	New	+$139K	0.03%	297

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pillar Pacific Capital Management's NBSE Position: Q1 2021 in Review

Pillar Pacific Capital Management sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2021, closing a stake of 990 shares — an estimated $138K sold.

Pillar Pacific Capital Management first reported a position in NBSE in Q4 2013 and held it in 12 quarters. The position peaked at $250K in Q1 2014. 56 funds tracked by Wall St. Rank hold NBSE as of Q1 2021.

Pillar Pacific Capital Management reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Pillar Pacific Capital Management sold 990 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $138K.
Pillar Pacific Capital Management first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2013 and held it in 12 quarters.
Pillar Pacific Capital Management's NeuBase Therapeutics, Inc. Common Stock position peaked at $250K in Q1 2014.
56 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.